A Review of Complementary and Alternative Approaches to Immunomodulation.
暂无分享,去创建一个
[1] L. Kopelovich,et al. Resveratrol: a review of preclinical studies for human cancer prevention. , 2007, Toxicology and applied pharmacology.
[2] B. Hyman,et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.
[3] A. Dobs,et al. Vitamin d and its role in cancer and immunity: a prescription for sunlight. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[4] Liz Y. Han,et al. Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway , 2007, Clinical Cancer Research.
[5] N. Nieto. Ethanol and fish oil induce NFκB transactivation of the collagen α2(I) promoter through lipid peroxidation–driven activation of the PKC‐PI3K‐Akt pathway , 2007 .
[6] P. Calder,et al. Immune modulation by parenteral lipid emulsions. , 2007, The American journal of clinical nutrition.
[7] J. Buckley,et al. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. , 2007, The American journal of clinical nutrition.
[8] R. Goldberg,et al. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain , 2007, Pain.
[9] O. Inatomi,et al. Curcumin Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis , 2007, Digestive Diseases and Sciences.
[10] M. Cantorna,et al. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury , 2007, BMC Immunology.
[11] H. Bays. Safety considerations with omega-3 fatty acid therapy. , 2007, The American journal of cardiology.
[12] N. Maulik,et al. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. , 2007, Journal of Molecular and Cellular Cardiology.
[13] F. Shanahan,et al. Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.
[14] A. Bonanomi,et al. The Vitamin D analogue TX 527 blocks NF-κB activation in peripheral blood mononuclear cells of patients with Crohn's disease , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[15] Jennifer L Jones,et al. The Role of Probiotics in Inflammatory Bowel Disease , 2007, Digestive Diseases and Sciences.
[16] Bharat B. Aggarwal,et al. “Spicing Up” of the Immune System by Curcumin , 2007, Journal of Clinical Immunology.
[17] C. Tartaglia,et al. Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical. , 2007, World journal of gastroenterology.
[18] M. Sata,et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[19] C. Gordon,et al. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease , 2006, Inflammatory bowel diseases.
[20] O. Werz,et al. Boswellic acids: biological actions and molecular targets. , 2006, Current medicinal chemistry.
[21] Irfan Rahman,et al. Regulation of inflammation and redox signaling by dietary polyphenols. , 2006, Biochemical pharmacology.
[22] P. Puigserver,et al. Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.
[23] A. Steinmeyer,et al. The New Low Calcemic Vitamin D Analog 22-Ene-25-Oxa-Vitamin D Prominently Ameliorates T Helper Cell Type 1-Mediated Colitis in Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.
[24] J. Milner,et al. Diet and Cancer: Facts and Controversies , 2006, Nutrition and cancer.
[25] R. Providência. Cardiovascular protection from alcoholic drinks: scientific basis of the French Paradox. , 2006, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[26] A. Simopoulos. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[27] C. Hawkey,et al. Probiotics for maintenance of remission in Crohn's disease. , 2006, The Cochrane database of systematic reviews.
[28] L. Dieleman,et al. Probiotics and prebiotics in chronic inflammatory bowel diseases. , 2006, World journal of gastroenterology.
[29] H. Ammon. Boswellic Acids in Chronic Inflammatory Diseases , 2006, Planta medica.
[30] Z. Halpern,et al. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis , 2006, Gut.
[31] Chang-sheng Deng,et al. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. , 2006, International immunopharmacology.
[32] Chang-sheng Deng,et al. Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. , 2006, World journal of gastroenterology.
[33] L. Barenghi,et al. Cardiovascular protective effects of resveratrol. , 2006, Cardiovascular drug reviews.
[34] N. Senninger,et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[35] Joseph A. Baur,et al. Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.
[36] T. Buclin,et al. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. , 2006, Clinical nutrition.
[37] Q. Ouyang,et al. Probiotics and inflammatory bowel diseases , 2006, Postgraduate Medical Journal.
[38] S. Willich,et al. Use of complementary and alternative medicine in Germany – a survey of patients with inflammatory bowel disease , 2006, BMC complementary and alternative medicine.
[39] T. Mickleborough,et al. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. , 2006, Chest.
[40] Reyes Artacho,et al. Beneficial Effects of Green Tea—A Review , 2006, Journal of the American College of Nutrition.
[41] W. Hunter,et al. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis , 2006, Inflammation Research.
[42] M. Sánchez-Hidalgo,et al. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model , 2006, British journal of pharmacology.
[43] A. Singh,et al. Multiple biological activities of curcumin: a short review. , 2006, Life sciences.
[44] Daniel Normolle,et al. Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.
[45] B. Aggarwal,et al. Acetyl-11-Keto-β-Boswellic Acid Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis by Suppressing NF-κB and NF-κB-Regulated Gene Expression1 , 2006, The Journal of Immunology.
[46] Antonino Cattaneo,et al. Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived Vertebrate , 2006, Current Biology.
[47] J. Funk,et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. , 2006, Journal of natural products.
[48] D. Rampton,et al. Review article: complementary and alternative therapies for inflammatory bowel disease , 2006, Alimentary pharmacology & therapeutics.
[49] D. Das,et al. Retracted: Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFκB , 2006 .
[50] S. Proudman,et al. Fish oil: what the prescriber needs to know , 2005, Arthritis research & therapy.
[51] V. Annese,et al. Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study , 2005 .
[52] M. Korabiowska,et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[53] J. Drewe,et al. Epigallocatechin-3-gallate Impairs Chemokine Production in Human Colon Epithelial Cell Lines , 2005, Journal of Pharmacology and Experimental Therapeutics.
[54] John Savill,et al. Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.
[55] S. Katz,et al. Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study , 2005, Digestive Diseases and Sciences.
[56] Namitha,et al. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. , 2005, The Indian journal of medical research.
[57] Thomas J. Sweet,et al. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. , 2005, Antiviral research.
[58] W. Mojica,et al. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. , 2005, American Journal of Clinical Nutrition.
[59] L. Neckers,et al. Metabolic and Pharmacological Properties of Rutin, a Dietary Quercetin Glycoside, for Treatment of Inflammatory Bowel Disease , 2005, Pharmaceutical Research.
[60] E. Mazzon,et al. Green tea polyphenol extract attenuates colon injury induced by experimental colitis , 2005, Free radical research.
[61] M. Diederich,et al. Chemopreventive and therapeutic effects of curcumin. , 2005, Cancer letters.
[62] C. McClain,et al. Antioxidants as novel therapy in a murine model of colitis. , 2005, The Journal of nutritional biochemistry.
[63] J. Goldblum,et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[64] D. Besselsen,et al. Effects of Boswellia serrata in mouse models of chemically induced colitis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[65] Jide Wang,et al. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. , 2005, World journal of gastroenterology.
[66] Takuji Tanaka,et al. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. , 2005, Biochemical pharmacology.
[67] M. Comalada,et al. In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF‐κB pathway , 2005, European journal of immunology.
[68] S. Walsh,et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial , 2005, Gut.
[69] Yan Zhu,et al. Calcium and 1α,25‐dihydroxyvitamin D3 target the TNF‐α pathway to suppress experimental inflammatory bowel disease , 2005 .
[70] J. Crowell,et al. Resveratrol-associated renal toxicity. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[71] M. Comalada,et al. The intestinal anti‐inflammatory effect of quercitrin is associated with an inhibition in iNOS expression , 2004, British journal of pharmacology.
[72] Charles N. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers , 2004, Lipids.
[73] A. Imaoka,et al. Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis , 2004, Alimentary pharmacology & therapeutics.
[74] M. Stolte,et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.
[75] C. Ruxton,et al. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2004, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[76] Chih-Hsing Wu,et al. The protective effect of habitual tea consumption on hypertension. , 2004, Archives of internal medicine.
[77] H. Nagawa,et al. Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b. , 2004, The Journal of allergy and clinical immunology.
[78] I. Villegas,et al. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. , 2004, Biochemical pharmacology.
[79] C. Rice-Evans,et al. Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.
[80] M. Westerterp-Plantenga,et al. Effects of green tea on weight maintenance after body-weight loss , 2004, British Journal of Nutrition.
[81] A. Bhardwaj,et al. Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. , 2004, Journal of nutritional science and vitaminology.
[82] Liang-Yi Wu,et al. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. , 2004, Journal of agricultural and food chemistry.
[83] Hao Jiang,et al. Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. , 2003, Biochemical pharmacology.
[84] J. Schölmerich,et al. Rationale for Probiotic and Antibiotic Treatment Strategies in Inflammatory Bowel Diseases , 2003, Digestive Diseases.
[85] Anton Rietveld,et al. Antioxidant effects of tea: evidence from human clinical trials. , 2003, The Journal of nutrition.
[86] Malcolm C Pike,et al. Green tea and risk of breast cancer in Asian Americans , 2003, International journal of cancer.
[87] Tetsuro Ito,et al. Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C. , 2003, Carcinogenesis.
[88] Chih-Hsing Wu,et al. Relationship among habitual tea consumption, percent body fat, and body fat distribution. , 2003, Obesity research.
[89] J. Hodgson,et al. Tea intake is inversely related to blood pressure in older women. , 2003, The Journal of nutrition.
[90] S. Katiyar. Skin photoprotection by green tea: antioxidant and immunomodulatory effects. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.
[91] D. Bennett,et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.
[92] A. Gomez-Muñoz,et al. Curcumin attenuates DNB-induced murine colitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[93] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 , 2003 .
[94] T. Borody,et al. Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy , 2003, Journal of clinical gastroenterology.
[95] P. Testoni,et al. A pilot trial of Saccharomyces boulardii in ulcerative colitis , 2003, European journal of gastroenterology & hepatology.
[96] S. Karmakar,et al. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitis , 2003, British journal of pharmacology.
[97] F. Chilton,et al. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. , 2003, Clinical therapeutics.
[98] F. Guarner,et al. Gut flora in health and disease , 2003, The Lancet.
[99] Yukio Koide,et al. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. , 2002, Gastroenterology.
[100] M. Polansky,et al. Tea enhances insulin activity. , 2002, Journal of agricultural and food chemistry.
[101] J. Zou,et al. Low dose of resveratrol enhanced immune response of mice. , 2002, Acta pharmacologica Sinica.
[102] Andy H. Lee,et al. Tea consumption and ovarian cancer risk: a case-control study in China. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[103] J. Quiles,et al. Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[104] K. Scott,et al. Fish consumption and self-reported physical and mental health status , 2002, Public Health Nutrition.
[105] G. Bulliyya. Influence of fish consumption on the distribution of serum cholesterol in lipoprotein fractions: comparative study among fish-consuming and non-fish-consuming populations. , 2002, Asia Pacific journal of clinical nutrition.
[106] A. Zarzuelo,et al. Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. , 2002, Life sciences.
[107] Christine D Wu,et al. Tea as a functional food for oral health. , 2002, Nutrition.
[108] J. Manson,et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.
[109] R. Belmaker,et al. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.
[110] J. Nóbrega,et al. Comparison of Heating Extraction Procedures for Al, Ca, Mg, and Mn in Tea Samples , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[111] K. Roemer,et al. Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse , 2001, International journal of cancer.
[112] James A. Hanley,et al. A Population-Based Case-Control Study of Lung Cancer and Green Tea Consumption among Women Living in Shanghai, China , 2001, Epidemiology.
[113] G. Ravagnan,et al. Effects of resveratrol on human immune cell function. , 2001, Life sciences.
[114] Xiaohua Gao,et al. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. , 2001, Biochemical pharmacology.
[115] C Poole,et al. Does tea affect cardiovascular disease? A meta-analysis. , 2001, American journal of epidemiology.
[116] B. Wong,et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[117] R. Lüdtke,et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. , 2001, Planta medica.
[118] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[119] Fajun Yang,et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. , 2001, The Journal of nutrition.
[120] M. Inoue,et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. , 2001, Cancer letters.
[121] Zuo-Feng Zhang,et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer , 2001, International journal of cancer.
[122] N. Senninger,et al. Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis , 2001, International Journal of Colorectal Disease.
[123] C. Elmets,et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. , 2001, Journal of the American Academy of Dermatology.
[124] W J van der Vijgh,et al. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[125] Weiya Ma,et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. , 2000, Carcinogenesis.
[126] E. Castanas,et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells , 2000, Journal of cellular biochemistry.
[127] G. Mullin,et al. ANTI‐IL12 IMPOSES THE DEATH SENTENCE ON Thl CELLS IN TNBS COLITIS—IS THERE A LIGHT AT THE END OF THE TUNNEL FOR CROHN'S DISEASE? , 2000, Inflammatory bowel diseases.
[128] A. Takeshita,et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. , 2000, Annals of epidemiology.
[129] O. Eremin,et al. Clinical response of ulcerative colitis with dietary omega-3 fatty acids: a double-blind randomized study , 2000 .
[130] H. Ishikawa,et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. , 2000, Journal of the American College of Nutrition.
[131] O. Eremin,et al. Clinical effect on ulcerative colitis with dietary supplementation by ष-3 fatty acids; a double blind, randomised study , 2000 .
[132] T. Tsujikawa,et al. Is fish oil (n-3 fatty acids) effective for the maintenance of remission in Crohn's disease? , 2000, Journal of Gastroenterology.
[133] L. Howells,et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.
[134] A. Hofman,et al. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. , 1999, Archives of internal medicine.
[135] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[136] B. Rembacken,et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial , 1999, The Lancet.
[137] P. Brigidi,et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis , 1999, Alimentary pharmacology & therapeutics.
[138] D. Kelly. Nutrition in inflammatory bowel disease , 1999, Current gastroenterology reports.
[139] V. Steele,et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.
[140] M. Inoue,et al. Effect of life styles on the risk of subsite-specific gastric cancer in those with and without family history. , 1999, Journal of epidemiology.
[141] J. Buring,et al. Coffee and tea intake and the risk of myocardial infarction. , 1999, American journal of epidemiology.
[142] S. Heys,et al. Distal procto-colitis, natural cytotoxicity, and essential fatty acids , 1998, American Journal of Gastroenterology.
[143] M. Stolte,et al. Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis , 1997, Alimentary pharmacology & therapeutics.
[144] Norman R. Farnsworth,et al. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.
[145] K. Ewe,et al. N-3 fatty acids only delay early relapse of ulcerative colitis in remission , 1996, Digestive Diseases and Sciences.
[146] A. Zarzuelo,et al. Effect of quercitrin on acute and chronic experimental colitis in the rat. , 1996, The Journal of pharmacology and experimental therapeutics.
[147] W. Fleig,et al. Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial , 1996 .
[148] M. Campieri,et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. , 1996, The New England journal of medicine.
[149] D Kromhout,et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.
[150] B. Joe,et al. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.
[151] E. Isolauri,et al. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. , 1993, Gastroenterology.
[152] C. Ainley,et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis , 1993, Alimentary pharmacology & therapeutics.
[153] G. Triadafilopoulos,et al. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. , 1992, The American journal of gastroenterology.
[154] C. Smith,et al. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. , 1991, Gut.
[155] H. Ammon,et al. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. , 1991, Planta medica.
[156] M. Garg,et al. Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. , 1991, Canadian journal of physiology and pharmacology.
[157] F. Guarner,et al. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. , 1990, Gut.
[158] A. Kornbluth,et al. Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. , 1990, Journal of clinical gastroenterology.
[159] T. Strasser,et al. Supplementation with n‐3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo‐controlled, double‐blind cross‐over trial , 1989, Journal of internal medicine. Supplement.
[160] O. P. Sharma. Antioxidant activity of curcumin and related compounds. , 1976, Biochemical pharmacology.
[161] A. Griffiths,et al. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. , 2009, The Cochrane database of systematic reviews.
[162] T. Terano,et al. Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases , 2007, Lipids.
[163] M. Amri,et al. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. , 2007, Archives of biochemistry and biophysics.
[164] N. Nieto. Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2(I) promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway. , 2007, Hepatology.
[165] J. Sayre,et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. , 2006, Journal of Alzheimer's disease : JAD.
[166] S. Katz. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. , 2006, Reviews in gastroenterological disorders.
[167] S. Bengmark. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. , 2006, JPEN. Journal of parenteral and enteral nutrition.
[168] Stig Bengmark,et al. Curcumin, An Atoxic Antioxidant and Natural NFκB, Cyclooxygenase-2, Lipooxygenase, and Inducible Nitric Oxide Synthase Inhibitor: A Shield Against Acute and Chronic Diseases. , 2006, JPEN. Journal of parenteral and enteral nutrition.
[169] D. Fuchs,et al. Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro , 2005, Clinical chemistry and laboratory medicine.
[170] V. Annese,et al. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. , 2005, World journal of gastroenterology.
[171] Yan Zhu,et al. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. , 2005, European journal of immunology.
[172] Y. Yamori,et al. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. , 2004, The Journal of nutrition.
[173] Andy H. Lee,et al. Protective effect of green tea against prostate cancer: A case‐control study in southeast China , 2004, International journal of cancer.
[174] J. Docherty,et al. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. , 2004, Antiviral research.
[175] V. Adhami,et al. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. , 2003, Toxicology and applied pharmacology.
[176] S. Pandol,et al. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[177] B. Aggarwal,et al. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. , 2003, Carcinogenesis.
[178] V. Raia,et al. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. , 2003, JPEN. Journal of parenteral and enteral nutrition.
[179] R. Repges,et al. [Therapy of active Crohn disease with Boswellia serrata extract H 15]. , 2001, Zeitschrift fur Gastroenterologie.
[180] H. Vogelsang,et al. Therapie des aktiven Morbus Crohn mit dem Boswellia-serrata-Extrakt H 15 , 2001 .
[181] M. Suganuma,et al. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. , 2000, BioFactors.
[182] R. Sartor,et al. Probiotics and inflammatory bowel diseases. , 2000, The American journal of gastroenterology.
[183] R. Lüdtke,et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. , 1997, European journal of medical research.
[184] W. Fleig,et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). , 1996, Scandinavian journal of gastroenterology.
[185] A. Sonnenberg,et al. Geographic variation of inflammatory bowel disease within the United States. , 1991, Gastroenterology.